PECI/ECI2 anticorps (C-Term)
Aperçu rapide pour PECI/ECI2 anticorps (C-Term) (ABIN2332973)
Antigène
Voir toutes PECI/ECI2 (PECI) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- PECI, CT (Peroxisomal 3,2-trans-enoyl-CoA Isomerase, ACBD2, Delta(3),delta(2)-enoyl-CoA Isomerase, D3,D2-enoyl-CoA Isomerase, Diazepam-binding Inhibitor-related Protein 1, DBI-related Protein 1, dJ1013A10.3, Dodecenoyl-CoA Isomerase, DRS1, DRS-1, Hepatocellular Carcinoma-associated Antigen 88, HCA88, KIAA0536, Renal Carcinoma Antigen NY-REN-1)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- Synthetic peptide selected from the C-terminal region of human PECI (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
-